{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:26:39Z","timestamp":1793607999321,"version":"4.5.0"},"reference-count":109,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574014"],"award-info":[{"award-number":["82574014"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijrobp.2026.05.060","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T18:36:36Z","timestamp":1781462196000},"page":"428-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dosimetric Parameters of the Heart and Its Substructures in Predicting Cardiac Events or Survival in Patients With Lung Cancer After Radiation Therapy: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"126","author":[{"given":"Xinyi","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suyang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2026.05.060_bib0001","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0002","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1200\/JCO.19.01162","article-title":"Long-term results of NRG oncology RTOG 0617: Standard-versus high-dose chemoradiotherapy with or without cetuximab for unresectable stage III non\u2013small-cell lung cancer","volume":"38","author":"Bradley","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0003","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jaccao.2024.05.009","article-title":"Baseline cardiac parameters as biomarkers of radiation cardiotoxicity in lung cancer: An NI-HEART analysis","volume":"6","author":"Walls","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110005","article-title":"Cardiac radiation dose is associated with inferior survival but not cardiac events in patients with locally advanced non-small cell lung cancer in the era of immune checkpoint inhibitor consolidation","volume":"190","author":"Yegya-Raman","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110544","article-title":"Prediction of new-onset atrial fibrillation in patients with non-small cell lung cancer treated with curative-intent conventional radiotherapy","volume":"201","author":"Tohidinezhad","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0006","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jamaoncol.2022.4202","article-title":"Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer","volume":"8","author":"Kim","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0007","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ijrobp.2018.05.066","article-title":"Radiation therapy is associated with an increased incidence of cardiac events in patients with small cell lung cancer","volume":"102","author":"Ferris","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0008","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/jamaoncol.2020.6332","article-title":"Association of left anterior descending coronary artery radiation dose with major adverse cardiac events and mortality in patients with non-small cell lung cancer","volume":"7","author":"Atkins","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0009","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.lungcan.2018.03.024","article-title":"Association between radiation heart dosimetric parameters, myocardial infarct and overall survival in stage 3 non-small cell lung cancer treated with definitive thoracic radiotherapy","volume":"120","author":"Lee","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0010","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.jtho.2018.05.028","article-title":"Dosimetric predictors of symptomatic cardiac events after conventional-dose chemoradiation therapy for inoperable NSCLC","volume":"13","author":"Yegya-Raman","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0011","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1200\/JCO.2016.70.0229","article-title":"Cardiac toxicity after radiotherapy for stage III non-small-cell lung cancer: Pooled analysis of dose-escalation trials delivering 70 to 90 gy","volume":"35","author":"Wang","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0012","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: Combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer","volume":"35","author":"Dess","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0013","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0014","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13014-025-02668-x","article-title":"Radiation-induced cardiac substructure damage and dose constraints: A review","volume":"20","author":"Li","year":"2025","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2017.07.053","article-title":"Radiation dose to heart base linked with poorer survival in lung cancer patients","volume":"85","author":"McWilliam","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0016","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jtho.2022.09.004","article-title":"Cardiac function modifies the impact of heart base dose on survival: A voxel-wise analysis of patients with lung cancer from the PET-plan trial","volume":"18","author":"Craddock","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0017","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clon.2023.11.029","article-title":"The association of incidental radiation dose to the heart base with overall survival and cardiac events after curative-intent radiotherapy for non-small cell lung cancer: Results from the NI-HEART study","volume":"36","author":"Walls","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0018","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00066-024-02339-y","article-title":"Evaluating the impact of cardiac substructure dosimetric parameters on survival in lung cancer patients undergoing postoperative radiotherapy","volume":"201","author":"Yilmaz","year":"2025","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.110821","article-title":"Association between dose to cardiac structures and overall survival: A multivariable analysis in a large, multi-institutional database of stage III NSCLC patients with external validation","volume":"206","author":"Garrett Fernandes","year":"2025","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0020","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIR.0000000000000156","volume":"132","author":"Hicks","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0021","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","volume":"66","author":"Hicks","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0022","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ijrobp.2025.06.3852","article-title":"Differential impact of left ventricular myocardium and left coronary radiation dose with incident heart failure and coronary events in lung cancer radiation therapy","volume":"123","author":"Zhang","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0023","doi-asserted-by":"crossref","first-page":"e420","DOI":"10.1016\/j.cllc.2025.05.002","article-title":"Combined impact of coronary artery calcification and heart radiation dose on overall survival in locally advanced non-small cell lung cancer: Who benefits most from reducing heart radiation dose?","volume":"26","author":"Watanabe","year":"2025","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0024","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.radonc.2021.03.001","article-title":"Ablative radiotherapy for ultracentral lung cancers: Dosimetric, geometric, and volumetric predictors of outcomes and toxicity","volume":"158","author":"Breen","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0025","article-title":"Are heart doses associated with survival in patients with non-small cell lung cancer who received post-operative thoracic radiotherapy?: A national population-based study","volume":"98","author":"Lee","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0026","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.radonc.2019.11.024","article-title":"High dose radiation therapy based on normal tissue constraints with concurrent chemotherapy achieves promising survival of patients with unresectable stage III non-small cell lung cancer","volume":"145","author":"Zhao","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0027","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.radonc.2021.03.026","article-title":"Is a higher estimated dose of radiation to immune cells predictive of survival in patients with locally advanced non-small cell lung cancer treated with thoracic radiotherapy?","volume":"159","author":"Yin","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0028","article-title":"Death without progression as an endpoint to describe cardiac radiation effects in locally advanced non-small cell lung cancer","volume":"39","author":"Yegya-Raman","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0029","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2018.10.029","article-title":"Doses of radiation to the pericardium, instead of heart, are significant for survival in patients with non-small cell lung cancer","volume":"133","author":"Xue","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s12672-025-02046-9","article-title":"Simultaneous integrated dose reduction intensity-modulated radiotherapy improves survival in patients with locally advanced non-small cell lung cancer by reducing cardiac irradiation exposure","volume":"16","author":"Xu","year":"2025","journal-title":"Discov Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0031","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.21037\/tlcr-20-831","article-title":"Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio associations with heart and body dose and their effects on patient outcomes in locally advanced non-small cell lung cancer treated with definitive radiotherapy","volume":"9","author":"Xia","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0032","doi-asserted-by":"crossref","first-page":"e241","DOI":"10.1016\/j.cllc.2017.08.002","article-title":"Survival impact of cardiac dose following lung stereotactic body radiotherapy","volume":"19","author":"Wong","year":"2018","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0033","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ijrobp.2021.08.017","article-title":"Coronary artery calcifications and cardiac risk after radiation therapy for stage III lung cancer","volume":"112","author":"Wang","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0034","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.radonc.2017.10.001","article-title":"Heart dosimetric analysis of three types of cardiac toxicity in patients treated on dose-escalation trials for stage III non-small-cell lung cancer","volume":"125","author":"Wang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0035","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.radonc.2016.02.011","article-title":"Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab","volume":"118","author":"Walraven","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109762","article-title":"Association between statin therapy dose intensity and radiation cardiotoxicity in non-small cell lung cancer: Results from the NI-HEART study","volume":"186","author":"Walls","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110085","article-title":"Pulmonary vein dose and risk of atrial fibrillation in patients with non-small cell lung cancer following definitive radiotherapy: An NI-HEART analysis","volume":"192","author":"Walls","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0038","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijrobp.2017.04.026","article-title":"The impact of cardiac radiation dosimetry on survival after radiation therapy for non-small cell lung cancer","volume":"99","author":"Vivekanandan","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0039","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.radonc.2021.10.016","article-title":"Associations between cardiac irradiation and survival in patients with non-small cell lung cancer: Validation and new discoveries in an independent dataset","volume":"165","author":"Vivekanandan","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0040","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.radonc.2019.07.028","article-title":"Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients","volume":"143","author":"van Diessen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0041","article-title":"The influence of cardiac substructure dose on survival in a large lung cancer stereotactic radiotherapy cohort using a robust personalized contour analysis","volume":"32","author":"van der Pol","year":"2024","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0042","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1080\/0284186X.2023.2260944","article-title":"Different benefits of adaptive radiotherapy for different histologies of NSCLC","volume":"62","author":"Tvilum","year":"2023","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0043","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.radonc.2016.04.025","article-title":"Impact of heart and lung dose on early survival in patients with non-small cell lung cancer treated with chemoradiation","volume":"119","author":"Tucker","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0044","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.radonc.2022.02.010","article-title":"Major adverse cardiac event risk prediction model incorporating baseline cardiac disease, hypertension, and logarithmic left anterior descending coronary artery radiation dose in lung cancer (CHyLL)","volume":"169","author":"Tjong","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0045","article-title":"External validation of cardiac disease, hypertension, and logarithmic left anterior descending coronary artery radiation dose (CHyLL) for predicting major adverse cardiac events after lung cancer radiotherapy","volume":"42","author":"Tjong","year":"2023","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0046","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.radonc.2017.09.004","article-title":"Heart dose associated with overall survival in locally advanced NSCLC patients treated with hypofractionated chemoradiotherapy","volume":"125","author":"Stam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0047","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.radonc.2017.04.017","article-title":"Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients","volume":"123","author":"Stam","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0048","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jtho.2016.09.134","article-title":"Heart dose is an independent dosimetric predictor of overall survival in locally advanced non\u2013small cell lung cancer","volume":"12","author":"Speirs","year":"2017","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0049","article-title":"Increasing heart dose reduces overall survival in patients undergoing postoperative radiation therapy for NSCLC","volume":"2","author":"Shepherd","year":"2021","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0050","doi-asserted-by":"crossref","first-page":"6091","DOI":"10.2147\/CMAR.S200837","article-title":"Association of lung and heart dose with survival in patients with non-small cell lung cancer underwent volumetric modulated arc therapy","volume":"11","author":"Shen","year":"2019","journal-title":"Cancer Manag Res"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0051","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1200\/JCO.2016.69.1378","article-title":"Impact of intensity-modulated radiation therapy technique for locally advanced non-small-cell lung cancer: A secondary analysis of the NRG oncology RTOG 0617 randomized clinical trial","volume":"35","author":"Chun","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0052","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.cllc.2020.11.003","article-title":"Safety and efficacy of stereotactic body radiotherapy in ultracentral lung tumors using a risk-optimized fractionation scheme","volume":"22","author":"Regnery","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0053","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaccao.2023.08.007","article-title":"Predicting adverse cardiac events after radiotherapy for locally advanced non\u2013small cell lung cancer","volume":"5","author":"No","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0054","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4236\/jct.2021.129044","article-title":"Using novel statistical techniques to accurately determine the predictive dose range in a study of overall survival after definitive radiotherapy for stage III non-small cell lung cancer in association with heart dose","volume":"12","author":"Niska","year":"2021","journal-title":"J Cancer Ther"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0055","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ijrobp.2017.05.022","article-title":"Incidence and predictors of pericardial effusion after chemoradiation therapy for locally advanced non-small cell lung cancer","volume":"99","author":"Ning","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0056","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.21037\/jtd.2019.06.29","article-title":"Heart V5 predicts cardiac events in unresectable lung cancer patients undergoing chemoradiation","volume":"11","author":"Ni","year":"2019","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0057","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ijrobp.2020.06.031","article-title":"Novel methodology to investigate the effect of radiation dose to heart substructures on overall survival","volume":"108","author":"McWilliam","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0058","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.radonc.2019.04.022","article-title":"Influence of tumour laterality on patient survival in non-small cell lung cancer after radiotherapy","volume":"137","author":"McWilliam","year":"2019","journal-title":"Radiother Oncol."},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0059","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.phro.2020.07.002","article-title":"Dose surface maps of the heart can identify regions associated with worse survival for lung cancer patients treated with radiotherapy","volume":"15","author":"McWilliam","year":"2020","journal-title":"Phys Imaging Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0060","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jtho.2023.01.085","article-title":"Demystifying the results of RTOG 0617: Identification of dose sensitive cardiac subregions associated with overall survival","volume":"18","author":"McWilliam","year":"2023","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0061","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.ijrobp.2022.11.033","article-title":"Left anterior descending coronary artery radiation dose association with all-cause mortality in NRG oncology trial RTOG 0617","volume":"115","author":"McKenzie","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0062","article-title":"Higher lung and heart doses decrease early and long-term survival, respectively, in patients with non-small cell lung cancer undergoing postoperative radiation","volume":"8","author":"Ma","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0063","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13014-017-0772-5","article-title":"Is pulmonary artery a dose-limiting organ at risk in non-small cell lung cancer patients treated with definitive radiotherapy?","volume":"12","author":"Ma","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0064","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.radonc.2021.10.012","article-title":"Surgical complications and clinical outcomes after dose-escalated trimodality therapy for non-small cell lung cancer in the era of intensity-modulated radiotherapy","volume":"165","author":"Liu","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0065","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1080\/0284186X.2019.1629011","article-title":"The effect of tumor laterality on survival for non-small cell lung cancer patients treated with radiotherapy","volume":"58","author":"J\u00f8rgensen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0066","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.radonc.2020.04.008","article-title":"Impact of small residual setup errors after image guidance on heart dose and survival in non-small cell lung cancer treated with curative-intent radiotherapy","volume":"152","author":"Johnson-Hart","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0067","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cllc.2016.06.004","article-title":"Matched-pair analysis of high dose versus standard dose definitive chemoradiation for locally advanced non\u2013small-cell lung cancer","volume":"18","author":"Johnson","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0068","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.radonc.2020.09.050","article-title":"Heart substructural dosimetric parameters and risk of cardiac events after definitive chemoradiotherapy for stage III non-small cell lung cancer","volume":"152","author":"Jang","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0069","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1016\/j.prro.2023.09.005","article-title":"Sinoatrial node dose is associated with worse survival in patients undergoing definitive stereotactic body radiation therapy for central lung cancers","volume":"14","author":"Iovoli","year":"2024","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0070","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00432-019-02903-5","article-title":"Circulating microRNAs as biomarkers of radiation-induced cardiac toxicity in non-small-cell lung cancer","volume":"145","author":"Hawkins","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0071","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.21037\/jtd-20-1792","article-title":"Implications of pneumonitis after chemoradiation and durvalumab for locally advanced non-small cell lung cancer","volume":"12","author":"Hassanzadeh","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0072","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1093\/annonc\/mdx069","article-title":"Heart dose exposure as prognostic marker after radiotherapy for resectable stage IIIA\/B non-small-cell lung cancer: Secondary analysis of a randomized trial","volume":"28","author":"Guberina","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0073","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.lungcan.2022.06.003","article-title":"Dosimetric predictors of pneumonitis in locally advanced non-small cell lung cancer patients treated with chemoradiation followed by durvalumab","volume":"170","author":"Gao","year":"2022","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0074","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.ijrobp.2019.11.397","article-title":"Long-term results from the IDEAL-CRT phase 1\/2 trial of isotoxically dose-escalated radiation therapy and concurrent chemotherapy for stage II\/III non-small cell lung cancer","volume":"106","author":"Fenwick","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.radonc.2019.03.029","article-title":"Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer","volume":"136","author":"Elhammali","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0076","article-title":"Predictors of pneumonitis in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiation followed by consolidative durvalumab","volume":"8","author":"Diamond","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0077","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.radonc.2018.05.017","article-title":"Cardiac dose is associated with immunosuppression and poor survival in locally advanced non-small cell lung cancer","volume":"128","author":"Contreras","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0078","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12149-022-01724-w","article-title":"Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET","volume":"36","author":"Cho","year":"2022","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0079","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.clon.2024.07.005","article-title":"Cardiac substructure dose and survival in stereotactic radiotherapy for lung cancer: Results of the multi-centre SSBROC trial","volume":"36","author":"Chin","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0080","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2020.05.051","article-title":"Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy","volume":"150","author":"Chen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0081","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cllc.2019.10.010","article-title":"Effect of radiation doses to the heart on survival for stereotactic ablative radiotherapy for early-stage non\u2013small-cell lung cancer: An artificial neural network approach","volume":"21","author":"Chan","year":"2020","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0082","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.cllc.2019.05.014","article-title":"Dosimetric predictors of cardiotoxicity in thoracic radiotherapy for lung cancer","volume":"20","author":"Borkenhagen","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0083","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fonc.2017.00001","article-title":"Results of a single institution experience with dose-escalated chemoradiation for locally advanced unresectable non-small cell lung cancer","volume":"7","author":"Bernard","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0084","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.1007577","article-title":"Heart dose and cardiac comorbidities influence death with a cardiac cause following hypofractionated radiotherapy for lung cancer","volume":"12","author":"Banfill","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0085","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jaccao.2024.07.005","article-title":"Cardiac substructure radiation dose and associations with tachyarrhythmia and bradyarrhythmia after lung cancer radiotherapy","volume":"6","author":"Atkins","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0086","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1016\/j.jacc.2019.03.500","article-title":"Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer","volume":"73","author":"Atkins","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0087","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.ijrobp.2022.07.440","article-title":"Association of cardiac sub-structure radiation dose with bradyarrhythmias and tachyarrhythmias after lung cancer radiotherapy","volume":"114","author":"Atkins","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0088","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ijrobp.2009.09.064","article-title":"Radiation-related heart disease: Current knowledge and future prospects","volume":"76","author":"Darby","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0089","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0167-8140(02)00133-0","article-title":"Detection of defects in myocardial perfusion imaging in patients with early breast cancer treated with radiotherapy","volume":"64","author":"Seddon","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0090","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1200\/JCO.2016.69.8480","article-title":"Validation and modification of a prediction model for acute cardiac events in patients with breast cancer treated with radiotherapy based on three-dimensional dose distributions to cardiac substructures","volume":"35","author":"Van Den Bogaard","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0091","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1093\/eurheartj\/ehad462","article-title":"Association of radiation dose to cardiac substructures with major ischaemic events following breast cancer radiotherapy","volume":"44","author":"Lai","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0092","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.1016\/j.ijrobp.2021.07.236","article-title":"Dosimetric predictors of cardiac events after concurrent chemoradiotherapy for locally advanced esophageal cancer","volume":"111","author":"Cai","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0093","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2020.07.1802","article-title":"The predictive value of substructure and whole heart dosimetric variables for cardiac events and overall survival in locally advanced esophageal cancer receiving chemoradiotherapy","volume":"108","author":"Cai","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.100969","article-title":"Cardiac substructures dosimetric predicts cardiac toxicity and prognosis in esophageal squamous cell cancer treated by radiotherapy","volume":"48","author":"Jin","year":"2024","journal-title":"Neoplasia"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0095","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacep.2025.04.001","article-title":"Atrial fibrillation in the young: Pathogenesis and clinical implications","volume":"11","author":"D\u2019Elia","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0096","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/hc0902.104712","article-title":"Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation","volume":"105","author":"Oral","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0097","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-022-00347-9","article-title":"Atrial fibrillation","volume":"8","author":"Brundel","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0098","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM199809033391003","article-title":"Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins","volume":"339","author":"Ha\u00efssaguerre","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0099","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1161\/01.CIR.0000074206.52056.2D","article-title":"Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy","volume":"107","author":"Lin","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0100","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/S0140-6736(05)67887-7","article-title":"Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials","volume":"366","author":"Clarke","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0101","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00006534-198507000-00027","article-title":"Gray\u2019s anatomy","volume":"76","author":"Goldwyn","year":"1985","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0102","doi-asserted-by":"crossref","first-page":"S497","DOI":"10.1016\/S0167-8140(21)06989-9","article-title":"OC-0633 Cardiac substructure avoidance in lung cancer using photon vs proton radiotherapy: A planning study","volume":"161","author":"Banfill","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0103","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","article-title":"Prognostic factors for advanced colorectal neoplasia in inflammatory bowel disease: Systematic review and meta-analysis","volume":"160","author":"Wijnands","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0104","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12874-015-0024-z","article-title":"The heterogeneity statistic I(2) can be biased in small meta-analyses","volume":"15","author":"von Hippel","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0105","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/j.prro.2019.07.013","article-title":"Cardiac dose in locally advanced lung cancer: Results from a statewide consortium","volume":"10","author":"Dess","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0106","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110061","article-title":"Deep learning-based automatic segmentation of cardiac substructures for lung cancers","volume":"191","author":"Chen","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0107","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijrobp.2021.09.009","article-title":"AI-based quantification of planned radiation therapy dose to cardiac structures and coronary arteries in patients with breast cancer","volume":"112","author":"van Velzen","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0108","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.radonc.2021.10.008","article-title":"Deep learning model for automatic contouring of cardiovascular substructures on radiotherapy planning CT images: Dosimetric validation and reader study based clinical acceptability testing","volume":"165","author":"Garrett Fernandes","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2026.05.060_bib0109","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.phro.2022.07.003","article-title":"Validation of an established deep learning auto-segmentation tool for cardiac substructures in 4D radiotherapy planning scans","volume":"23","author":"Walls","year":"2022","journal-title":"Phys Imaging Radiat Oncol"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626008394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626008394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:34:20Z","timestamp":1793604860000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626008394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":109,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0360301626008394"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.05.060","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dosimetric Parameters of the Heart and Its Substructures in Predicting Cardiac Events or Survival in Patients With Lung Cancer After Radiation Therapy: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.05.060","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}